BRIEF-Argent Biopharma Enters Long Term Aquiol Licensing And Supply Agreement

Royce Global

Royce Global

RGT

0.00

May 25 (Reuters) - Argent BioPharma Ltd RGT.AX:

  • LONG TERM AQUIOL LICENSING AND SUPPLY AGREEMENT

  • ENTERS LONG-TERM LICENSING AND SUPPLY AGREEMENT WITH THE SKIN HEALTH INSTITUTE

  • AGREEMENT INCLUDES €3,000 MONTHLY ROYALTY PLUS 5% REVENUE-LINKED ROYALTY

  • AGREEMENT GRANTS EXCLUSIVE WORLDWIDE USE OF AQUIOL FOR DERMATOLOGY COSMETIC APPLICATIONS

  • ESTABLISHES LONG-TERM SUPPLY ARRANGEMENT FOR SHI TO SOURCE AQUIOL FROM ARGENT BIOPHARMA

  • AGREEMENT INCLUDES COLLABORATION PROVISIONS FOR U.S. DERMATOLOGY AND COSMETIC MARKETS

Further company coverage: RGT.AX


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.